Recommendations of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia
Chronic myelogenous leukemia (cml) is a disease characterized by the expression of Bcr/Abl, an oncogenic protein tyrosine kinase, and by evolution over time from a relatively benign chronic phase to a rapidly fatal cml blast crisis. Until recently, the standard of care included potentially curative...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Multimed Inc.
2006
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394607/ |